E-LIB Suche - Ergebnisse für: Osonoi, Takeshi - Sprache DE

Personensuche X

Sortierung: Jahr

Sortierung: Relevanz

1

Comparison of Efficacy between Pemafibrate and Omega-3-Acid..:

Sumida, Yoshio ; Toyoda, Hidenori ; Yasuda, Satoshi...
Journal of Atherosclerosis and Thrombosis. , 2024

Link: https://doi.org/10.5551/..

2

Tofogliflozin long-term effects on atherosclerosis progress..:

Katakami, Naoto ; Mita, Tomoya ; Yoshii, Hidenori...
Cardiovascular Diabetology. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

3

Comparative evaluation of clinical glycemic control markers..:

Osonoi, Takeshi ; Shirabe, Shinichiro ; Saito, Miyoko...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Front Cover:

Rossing, Peter ; Garweg, Justus G. ; Anker, Stefan D....
Diabetes, Obesity and Metabolism. 25 (2023) 3 - p. , 2023

Link: https://doi.org/10.1111/..

5

Dapagliflozin Improves Erythropoiesis and Iron Metabolism i..:

Osonoi, Takeshi ; Shirabe, Shinichiro ; Saito, Miyoko...
Diabetes, Metabolic Syndrome and Obesity. 16 (2023) - p. 1799-1808 , 2023

Link: https://doi.org/10.2147/..

6

Efficacy and safety of switching from febuxostat to dotinur..:

Osonoi, Takeshi ; Saito, Miyoko ; Hosoya, Mitsuru...
Frontiers in Endocrinology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Glycaemic control, body weight, and safety of tirzepatide v..:

Osonoi, Takeshi ; Oura, Tomonori ; Hirase, Tetsuaki
Diabetes, Obesity and Metabolism. 26 (2023) 1 - p. 126-134 , 2023

Link: https://doi.org/10.1111/..

8

Long-term efficacy and safety of early alogliptin initiatio..:

Mita, Tomoya ; Katakami, Naoto ; Yoshii, Hidenori...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

9

Continuous glucose monitoring-derived time in range and CV ..:

Mita, Tomoya ; Katakami, Naoto ; Okada, Yosuke...
Diabetologia. 66 (2023) 12 - p. 2356-2367 , 2023

Link: https://doi.org/10.1007/..

10

Tofogliflozin long-term effects on atherosclerosis progress..:

Naoto Katakami ; Tomoya Mita ; Hidenori Yoshii...
https://doi.org/10.1186/s12933-023-01879-4. , 2023

Link: https://doi.org/10.1186/..

11

Comparative evaluation of clinical glycemic control markers..:

Takeshi Osonoi ; Shinichiro Shirabe ; Miyoko Saito...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1205021/full. , 2023

Link: https://doi.org/10.3389/..

12

Long-term efficacy and safety of early alogliptin initiatio..:

Mita, Tomoya ; Katakami, Naoto ; Yoshii, Hidenori...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480471/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Dapagliflozin Improves Erythropoiesis and Iron Metabolism i..:

Osonoi, Takeshi ; Shirabe, Shinichiro ; Saito, Miyoko...
info:eu-repo/semantics/altIdentifier/doi/10.2147/DMSO.S411504. , 2023

Link: https://www.dovepress.co..

14

Long-term efficacy and safety of early alogliptin initiatio..:

Tomoya Mita ; Naoto Katakami ; Hidenori Yoshii...
https://doi.org/10.1038/s41598-023-41036-1. , 2023

Link: https://doi.org/10.1038/..

15

Effect of finerenone on occurrence of vision-threatening co..:

Rossing, Peter ; Garweg, Justus G ; Anker, Stefan D...
https://boris.unibe.ch/174516/. , 2023

Link: https://boris.unibe.ch/1..

1-15